NBJ Summit 2025 Brings Industry Visionaries Together to Shape Nutrition's Future
RANCHO PALOS VERDES, CA / ACCESS Newswire / June 11, 2025 / The nutrition and dietary supplements industry's premier gathering, NBJ Summit 2025, will convene top executives and thought leaders at the Terranea Resort in Rancho Palos Verdes, Calif. from July 28-31, 2025. With the central theme of 'Nutrition Industry Transformation,' this year's summit addresses the seismic shifts reshaping the nearly $70 billion dollar industry landscape. This year's event comes at a critical time, promising to mobilize leaders around topics presenting challenges and opportunities for consumers and the industry.
The NBJ Summit, hosted by New Hope Network, offers an unparalleled opportunity for industry leaders to engage in four days of intensive education, strategic networking and forward-thinking discussions about the future of nutrition and dietary supplements. The State of the Industry presentation featuring Nutrition Business Journal (NBJ) industry data will set the stage for the week.
'In an era of exponential change, this year's agenda directly confronts the forces reshaping our industry and provides executives with actionable strategies to thrive amid disruption,' says Jessica Rubino, VP of Content and Summits, who serves as NBJ Summit Co Chair, along with Bill Giebler, Nutrition Business Journal Content & Insights Director, and Tom Aarts, NBJ Summit Founder 'We're bringing together the most innovative leaders to navigate this new landscape where healthcare and supplement industry convergence, digital transformation, regulatory shifts and personalized nutrition are fundamentally reshaping our industry.'
The 2025 agenda addresses four critical transformation areas:
A disruptive perspective on healthcare economics will be delivered by Calley Means, Co-Founder of Truemed, featuring compelling data demonstrating nutrition's critical role in addressing systemic health challenges. Complementing this vision, Dr. Lise Alschuler will reveal clinical pathways reshaping patient care, while James LaValle demonstrates how scientific insights create market advantages for forward-thinking companies. Dr. William Davis rounds out this powerful segment by sharing an influential vision for the nutrition-centered health transformation changing consumer expectations.
Business transformation renders yesterday's business models obsolete, and the Summit brings together leading experts in technology and innovation. AI specialists Mitch Mitchum, HIVE Interactive; Afif Ghannoum, CPG Radar; and Akash Shah, IngredientAI will reveal strategic applications of artificial intelligence that are driving growth across the nutrition value chain. Plus, innovation catalyst Diana Kander delivers a highly anticipated keynote on curiosity-driven innovation, offering attendees a rare opportunity to learn from one of today's most sought-after business advisors whose insights have transformed companies across multiple industries.
The regulatory landscape continues to evolve at an unprecedented pace, creating both challenges and opportunities for nutrition businesses. Industry advocates Douglas 'Duffy' MacKay, ND; Miriam Guggenheim of Covington & Burling LLP; and Steve Mister, Esq., President & CEO of the Council for Responsible Nutrition, will provide essential insights on compliance challenges and policy shifts reshaping the competitive landscape. MacKay and Mister's collective expertise offers attendees a comprehensive understanding of how to navigate complex regulatory environments while maintaining competitive advantage.
As the future of nutrition and retail are increasingly individualized, the Summit aims to showcase the pioneers leading this revolution. Biohacking phenomenon Ben Greenfield will share cutting-edge optimization techniques that are redefining consumer expectations around personalized nutrition. Renowned longevity researcher Brian Kennedy will reveal breakthroughs in cognitive enhancement, creating entirely new market categories. Retail experts from Amazon, TikTok and more will also share invaluable insights on emerging trends shaping the future of supplement retail in a personalized and omnichannel world, offering attendees practical strategies for adapting to rapidly evolving consumer behaviors and expectations.
The Summit culminates in an Executive Wellness Experience featuring a meticulously crafted Wellness Lunch, intimate networking with industry leaders and hands-on experiences with emerging biohacking modalities, nourishing wellness treatments and functional libations.
The NBJ Summit welcomes top nutrition industry CEOs and executives to this exclusive in-person event. For registration information and the complete agenda, visit www.nbjsummit.com.
NBJ Summit offers virtual registration to all who are interested. Virtual participants will have access to all education sessions, networking opportunities and will be able to connect with both in-person and virtual attendees on the virtual event platform. For more information, please visit www.nbjsummit.com/en/Register.html
About Nutrition Business Journal
Nutrition Business Journal guides decision makers in the nutrition, health, and wellness space in developing their strategy, understanding trends, realizing opportunity, and analyzing potential risks. NBJ's market research reports provide business intelligence and thought leadership to all levels of the nutrition industry. Each report is exhaustively researched by our staff of industry experts and presents an analysis of markets, trends, competition, and strategy in the U.S. and global nutrition industry. Learn more at nutritionbusinessjournal.com.
About Informa Markets
Informa Markets, a subsidiary of Informa plc (LON:INF), creates platforms for industries and specialist markets to trade, innovate and grow. With a global reach and diverse portfolio of verticals, including Pharmaceuticals, Food, Medical Technology and Infrastructure, Informa Markets connects buyers and sellers worldwide through face-to-face exhibitions, targeted digital services and actionable data solutions. For more information, visit www.informamarkets.com.
Media Contact
[email protected]
SOURCE: New Hope Network
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial
Israel's Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)'s Institute for Psychedelic Research located at the Sagol Brain Institute (SGI) in Tel-Aviv Sourasky Medical Center. Be'er Yaakov Mental Hospital (Merhavim) Center for Psychedelic Studies. For more information or to register visit (Canada) and (Israel). VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the approval by the Israeli MoH and IRBs to open two additional clinical trial sites for SUMMIT-90. The trial is a double-blind, placebo controlled phase 2b study evaluating multiple doses of APEX-90, a psilocybin macrodose utilizing APEX's US patent pending capsule. APEX-90 is administered in-clinic with study-assisted psychotherapy for severe depression within diagnosed PTSD. Israel is facing a severe mental health crisis: 44% of adults report depression and 42% PTSD, far above the 8–13% depression and 6–10% PTSD rates seen in the US and Canada. This MoH approval leverages the expertise of TAU's renowned SGI and Merhavim Hospital, which both have a rich history of pioneering research in neurological sciences. Their cutting-edge facilities and teams profound understanding of PTSD dynamics are poised to add patient recruitment expertise. 'I am honoured to have been able to facilitate this new partnership; another example of building important bridges between Canada and Israel in innovative clinical research, which will result in advancing patient access to emerging treatments,' says Sharon J. Fraenkel, TAU Canada's CEO for Ottawa, Quebec, and Atlantic Canada, on behalf of the organization. 'As someone deeply connected to Israel, witnessing the toll of PTSD among my loved ones, I'm driven to lead research that brings hope and healing,' says Alysa Langburt, APEX's VP of Global Clinical Development. 'This marks more than a clinical milestone, it represents a fundamental step towards transforming the mental health landscape in Canada and Israel, where the need has never been greater. Through our incredible partnerships, we aim to catalyze a shift in access, care and outcomes for those suffering with PTSD.' "SUMMIT-90 offers a beacon of hope for the significant numbers suffering from PTSD in Canada and Israel,' says Tyler Powell, co-Founder and CEO of APEX. 'It underscores our commitment to global mental health innovation and our belief in the opportunity for clinically proven psilocybin therapies to transform mental health care.' About Apex Labs is a patient-driven pharmaceutical company focused on revolutionizing the standard of mental health care with psilocybin. APEX's strategy is two-pronged, clinical evaluation of drug assets alongside a robust Early Access Program. APEX recognizes and prioritizes Veterans as a patient base with the most severe unmet medical need. Visit for more information and follow APEX on LinkedIn, Twitter and Instagram. Forward-Looking StatementsThis release contains certain "forward-looking statements" and certain "forward-looking information" as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", "continue", "plans" or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability to control or predict, that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: receiving authorization of Health Canada Dealers Licence; filing US provisional patent, the Company evaluating the safety and efficacy of APEX-52 (psilocybin) and APEX-90 (psilocybin) in treating depression in Veterans and patients with Post-Traumatic Stress Disorder; statements related to APEX-52 and APEX-90, including manufacturing, dosing, and trial details; statements made by the Company's executives with respect to Health Canada's Dealer's Licence and capsule patent filing; the Company's efforts around the Early Access Program; statements made relating to Canadian Veteran patients; approvals by the Israeli Ministry of Health and ethics; the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements' best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. SOURCE Apex Labs Ltd. CONTACT: For further information: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Global Longevity Summit 2025: Spotlight on Dr. Steve Horvath, New Advisory Board Members, and Early Registration Opportunity
Informa Connect's Global Longevity Summit continues to break new ground in the science of aging and human performance with the announcement of its 2025 keynote speaker, new advisory board appointments, and a call to act before the upcoming ticket price increase. GENEVA, SWITZERLAND, June 12, 2025 (GLOBE NEWSWIRE) -- Biogerontologist and epigenetic researcher Dr. Steve Horvath will headline the event as its keynote speaker and will be formally recognized as the recipient of the 2025 Global Longevity Award for his exceptional work in the development of the epigenetic clock - a breakthrough that continues to reshape our understanding of biological aging and predictive biomarkers. The Global Longevity Summit convenes from October 28–30, 2025, at the Genolier Innovation Hub in Geneva, Switzerland. The event brings together a distinguished cohort of 300 global leaders across healthcare, science, business, and capital. Under this year's theme, 'Mastering the Aging Clock: The Science of Longevity,' the program will feature cutting-edge insight into epigenetics, regenerative medicine, AI-powered health optimization, and precision intervention strategies. The Summit also expands its leadership circle with new Scientific and Professional Advisory Board members, each selected for their expertise in advancing healthy human lifespan. These new appointments reinforce the event's global vision and commitment to multidisciplinary innovation. This year's event is shaping up to be the most anticipated yet - and with demand rising, early registration is strongly encouraged. Ticket prices will increase on July 1, and delegate spots are limited. Interested participants are urged to secure access now to avoid missing this landmark opportunity. The Global Longevity Summit is an invitation-only event requiring participant approval. Qualified professionals and executives in the longevity ecosystem may apply to join at About the Global Longevity SummitThe Global Longevity Summit is the definitive gathering of international leaders dedicated to advancing human longevity through scientific innovation and strategic collaboration. The invitation-only conference unites experts, entrepreneurs, and investors to accelerate breakthroughs in life extension and power the future of healthy aging. CONTACT: Drew Wilson Global Longevity Summit (+1) 713-725-8983
Business Wire
8 hours ago
- Business Wire
GK Digital Ventures to Launch 'The Global Game: The Future of Soccer, Tech & Media Summit' Adjacent to FIFA Club World Cup™ Final
NEWARK, N.J.--(BUSINESS WIRE)--GK Digital Ventures, in collaboration with Harris Blitzer Sports & Entertainment (HBSE), today announced 'The Global Game: The Future of Soccer, Tech & Media Summit,' set to take place on July 10, 2025, at Prudential Center in Newark, NJ and will be supported by the New Jersey Economic Development Authority (NJEDA). The landmark event will coincide with the FIFA Club World Cup™, spotlighting New Jersey's growing role as a hub for innovation in global sports, media, and technology. It's about more than soccer—it's about how technology is reshaping everything from how we play to how we connect with fans around the world. Share With the overall theme 'Innovation at the Intersection of Soccer, Media, and Technology,' the Summit will convene top soccer executives, investors, team owners, media executives, tech leaders, and athletes for a day of future-focused discussions and unparalleled networking. Key topics include AI-driven performance, fan engagement, streaming innovation, and the expanding global footprint of soccer. Registration for 'The Global Game: The Future of Soccer, Tech & Media Summit' will be available on beginning Friday, June 13 at 12:00pm ET. For more information on event partnership opportunities please visit 'This summit reflects the next wave of innovation in global sports,' said Greg Kahn, CEO of GK Digital Ventures and Co-Founder of the event. 'It's about more than soccer—it's about how technology is reshaping everything from how we play to how we connect with fans around the world. I'm proud to partner with HBSE and the NJEDA to make New Jersey the launchpad for these conversations and collaborations.' 'As New Jersey steps onto the global stage—hosting the 2025 FIFA Club World Cup and 2026 World Cup Finals—we are excited to welcome The Global Game: The Future of Soccer, Tech & Media Summit to the Garden State,' said Governor Phil Murphy. 'As one of the premier locations for world-class sporting events and technology innovation, we are proud to welcome the world's best minds to our state to explore the future of the industry. New Jersey is where cutting-edge technology, creative storytelling, and passion for sport come together, building the next generation of content and experiences.' 'Under Governor Murphy's leadership, New Jersey has become a premier destination for large-scale sporting events – from March Madness to the World Cup,' said NJEDA Chief Executive Officer Tim Sullivan. 'The NJEDA is proud to sponsor this inaugural summit, which is an opportunity to connect New Jersey's global sports ecosystem with its thriving innovation economy – opening new doors for investment and job creation.' 'The convergence of sports, media, and technology has never been more powerful,' said Tad Brown, Chief Executive Officer, Harris Blitzer Sports & Entertainment. 'Our entire organization is very thankful to work in collaboration with Governor Murphy, the NJEDA, and Greg Kahn on this monumental summit. We are confident that the discussions taking place here in Newark on July 10 th will play an important role in shaping the future of the sport and its business.' 'As momentum builds toward the FIFA World Cup in 2026, events like this reflect the kind of forward-thinking energy that defines our region,' said Alex Lasry, CEO of the NYNJ Host Committee. 'New Jersey isn't just hosting eight matches, including the world's biggest game—we're helping shape the global conversation around the future of soccer.' Moderators and panelists confirmed to date include senior leaders from HBSE, Disney, U.S. Soccer, Paramount/CBS Sports, Fanatics, TEG Sport North America, and the FIFA World Cup 2026™ NYNJ Host Committee. Additional speakers and participants from across the global soccer, media, and tech industries will be announced soon — including, media executives, investors, and technology leaders, and top athletes who are shaping the future of the game. About GK Digital Ventures GK Digital Ventures is an investment and advisory firm focused on emerging media and technology, known for launching category-defining summits and building high-impact industry coalitions. About NJEDA The New Jersey Economic Development Authority is committed to driving inclusive, innovation-led economic growth across the Garden State. About Prudential Center Prudential Center is the world-class sports and entertainment venue located in downtown Newark, New Jersey. Opened in October 2007, the state-of-the-art arena is the home of the National Hockey League's (NHL) three-time Stanley Cup Champion New Jersey Devils, Seton Hall University's NCAA Division I Men's Basketball program, Professional Women's Hockey League's (PWHL) New York Sirens and more than 210 concerts, family shows and special events each year. Ranked in the Top 10 worldwide by Pollstar, Billboard and various other industry publications, Prudential Center is recognized as one of the premier venues in the United States, and hosts over 2 million guests annually. For more information about Prudential Center, visit and follow the arena on Facebook, X, Instagram, and TikTok @PruCenter. Prudential Center is a HBSE property.
